share_log

Wells Fargo Downgrades Axonics to Equal-Weight, Raises Price Target to $71

Benzinga ·  Jan 10 06:50

Wells Fargo analyst Larry Biegelsen downgrades Axonics (NASDAQ:AXNX) from Overweight to Equal-Weight and raises the price target from $68 to $71.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment